SYNG:BSESYNGENE FUTURES Analysis
Data as of 2026-05-25 - not real-time
CN¥6.54
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at 6.54 CNY, notably below its 20‑day SMA of 6.999 and 50‑day SMA of 6.802, indicating short‑term weakness despite a longer‑term bullish trend as the 200‑day SMA sits at 5.877. Volume is increasing and the 30‑day volatility is elevated at 83.7%, suggesting heightened price swings. The MACD shows a bearish divergence (histogram -0.093) and the RSI at 44 points to a neutral but not oversold condition, while the Fear & Greed Index registers an “Extreme Greed” reading of 91.6, reflecting strong market optimism. Support sits at 5.60 and resistance at 9.26, giving ample upside potential if the price can recover above the short‑term averages. Given the low computed beta (0.03) and a moderate drawdown of -31%, the equity exhibits limited systematic risk but remains sensitive to its own volatility profile.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below 20‑day SMA
- bearish MACD histogram
- proximity to near‑term support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- bullish longer‑term SMA alignment
- increasing volume trend
- extreme greed sentiment supporting upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- low systematic beta reducing market risk
- price far from 52‑week high, offering upside to resistance
- potential recovery driven by broader tech sector growth
Key Metrics & Analysis
Commodity Metrics
Spot Price6.54
Futures CurveFlat
Inventory LevelMedium
Supply/Demand RegimeBalanced
USD SensitivityLow
Rates SensitivityLow
Geopolitical SensitivityMedium
Technical Analysis
TrendBullish
RSI44.3
SupportCN¥5.60
ResistanceCN¥9.26
MA 20CN¥7.00
MA 50CN¥6.80
MA 200CN¥5.88
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61
Risk Assessment
Beta0.03
Volatility83.75%
Sector RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.